Core Scientific stock slips below $19.38 support as weak momentum weighs
Core Scientific (CORZ) stock is trading at $21.05, marking a daily decline of 3.31%. The stock is positioned below its key moving averages in the short and medium term, indicating recent selling pressure.
12.80
14.23
Highlights
- CORZ stock remains in a long-term uptrend but currently faces strong short- and medium-term selling pressure.
- Technical indicators show bearish momentum dominates, with sellers in control and oscillators indicating an oversold environment.
- The expected trading range is $19.38 to $22.72 over the next few days, with high downside risk and limited rebound potential.
Downward momentum persists amid weak signals and resistance pressure
On the technical front, CORZ has slipped below the MA-20 ($22.23) and MA-50 ($21.52) on the h1 timeframe, while remaining above its longer-term MA-200 ($19.76). The Ichimoku Kijun at $22.26 now acts as immediate resistance. Momentum signals are generally weak: the MACD is set to Sell, ADX is neutral, and RSI stands at 40.19, reflecting mild selling pressure. Both Stochastic RSI and CCI register oversold readings, suggesting downside exhaustion, but Bull/Bear Power confirms that sellers dominate intraday activity.
Bearish scenario prevails as downside risks outweigh rebound odds
Over the next two to three trading days, CORZ is expected to fluctuate between $19.38 and $22.72, reflecting a typical volatility band relative to current levels. There is a very high probability of further downside and only a low probability of an upward move, making a sustained rebound unlikely for now. A bullish scenario would require a breakout above $22.26, while a breach of $19.38 support would confirm continued weakness.
Previously it was reported that Core Scientific faced heightened technical risks and maintained a sideways-to-downward trading bias amid broader industry headwinds. The current analysis strengthens this outlook with definitive bearish momentum and highlights the risk of sustained weakness if support at $19.38 fails in the coming sessions.
Latest Core Scientific News
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
